No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditions
|
557174 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
1043 |
4. Check minimum number of eventsNone |
1043 |
5. Include endpoints |
3443 |
6. Filter based on genotype QC (FinnGen only) |
3029 |
Control definitions (FinnGen only)
- Control conditions
- not C3_CML_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Myeloproliferative diseases (CML excluded)
based on the number of shared cases.
Similar with more cases:
- Myeloproliferative diseases
- Liquid cancers
- Liquid cancers, including Hilmo
- Malignant neoplasm
- Malignant neoplasm, including Hilmo
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3029 | 1621 | 1408 |
| Unadjusted period prevalence (%) | 0.61 | 0.58 | 0.65 |
| Median age at first event (years) | 64.23 | 62.83 | 65.85 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3105
- Matched controls
- 31050
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
TPH00, ,
SPAT
150.3
315.2
157
11
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
+∞
307.7
1438
*
D75.2
ICD-10 Finland
Essential thrombocytosis
5163.0
307.7
1079
*
L03AB05
ATC
interferon alfa-2b; parenteral
118.9
307.7
221
20
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
41.2
307.7
387
107
B99
ICPC
Blood/lymph/spleen disease other
67.0
307.7
189
30
9950/3-C42.1
ICD-O-3
Polycythemia vera of bone marrow
+∞
307.7
466
*
XW000
NOMESCO Finland
Bone marrow biopsy
23.5
307.7
1018
632
TPH00
NOMESCO Finland
Phlebotomy
317.5
307.7
460
17
L01XX05
ATC
hydroxycarbamide; oral
7942.2
307.7
1850
7
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
74.6
307.7
260
38
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
5733.7
307.7
496
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
95.3
307.7
2008
585
D45
ICD-10 Finland
Polycythaemia vera
2051.2
307.7
1307
11
SPAT1074
SPAT
Venesection
158.7
307.7
314
22
9962/3-C42.1
ICD-O-3
Essential thrombocythemia of bone marrow
+∞
307.7
544
*
L01XX35
ATC
anagrelide; oral
+∞
279.5
264
*
9961/3-C42.1
ICD-O-3
Primary myelofibrosis of bone marrow
2490.2
252.4
241
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.7
195.0
794
2669
D75.1
ICD-10 Finland
Secondary polycythaemia
22.0
176.2
131
62
9960/3-C42.1
ICD-O-3
Myeloproliferative neoplasm, NOS, of bone marrow
830.5
162.1
158
*
174
Kela drug reimbursment
Ruxolitinib
+∞
156.6
149
*
B74
ICPC
Malignant neoplasm blood other
47.1
148.4
87
19
374
Kela drug reimbursment
Ruxolitinib
+∞
144.9
138
*
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
22.4
138.5
102
47
L03AB04
ATC
interferon alfa-2a; parenteral
201.5
130.7
135
7
L01EJ01
ATC
ruxolitinib; oral
+∞
128.0
122
*
M04AA01
ATC
allopurinol; systemic
2.9
121.3
722
2958
R79.9
ICD-10 Finland
Abnormal finding of blood chemistry, unspecified
15.6
118.2
103
68
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.2
111.5
497
1722
R79.8
ICD-10 Finland
Other specified abnormal findings of blood chemistry
13.2
111.4
107
84
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
28.1
109.4
74
27
B28
ICPC
Limited function/disability (B)
21.0
106.0
80
39
212
Kela drug reimbursment
Gout
6.4
102.6
175
287
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
7.4
76.8
113
158
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
18.3
76.0
61
34
L01XE18
ATC
[U] ruxolitinib
+∞
74.3
71
*
L03AA04, ,
ATC
26.8
65.5
45
17
WW500
NOMESCO Finland
Blood transfusion
3.6
64.2
220
638
B04
ICPC
Blood symptom/complaint
11.0
63.6
68
63
B03XA02
ATC
darbepoetin alfa; parenteral
4.5
59.4
147
336
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
18.9
54.4
43
23
D75.0
ICD-10 Finland
Familial erythrocytosis
67.9
52.3
60
9
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
20.2
52.1
40
20
XX7BT
NOMESCO Finland
Radioactive phosphorus therapy
+∞
51.2
49
*
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
7.7
46.3
65
86
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
17.8
45.5
37
21
B01AB05
ATC
enoxaparin; parenteral
1.7
43.0
1103
7506
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
41.3
1663
12705
D75.8
ICD-10 Finland
Other specified diseases of blood and blood-forming organs
54.1
40.5
48
9
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
8.8
37.5
47
54
B03XA01
ATC
erythropoietin; parenteral
6.0
35.6
63
107
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
10.1
32.7
37
37
I81
ICD-10 Finland
Portal vein thrombosis
8.8
31.9
40
46
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.4
31.8
238
1052
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
8.2
31.6
42
52
L01AB01
ATC
busulfan; systemic
+∞
31.3
30
*
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.3
28.7
227
1027
2384A
ICD-9 Finland
Neoplasm of uncertain behaviour of other and unspecified sites and tissues, Polycythaemia vera
+∞
28.2
27
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
27.8
972
6978
B01AC14
ATC
[U] anagrelide
+∞
27.1
26
*
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
3.5
24.5
85
248
R50.9
ICD-10 Finland
Fever, unspecified
1.7
23.5
478
2983
S97
ICPC
Chronic ulcer skin
2.0
23.3
253
1295
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.4
22.7
160
688
R04.0
ICD-10 Finland
Epistaxis
1.9
22.5
285
1540
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
22.4
704
4890
D47.0
ICD-10 Finland
Histiocytic and mast cell tumours of uncertain and unknown behaviour
45.3
22.4
27
6
C03CA01
ATC
furosemide; systemic
1.5
21.9
1090
8337
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.8
21.7
390
2348
B75
ICPC
Neoplasm blood benign/unspecified
115.8
21.6
23
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.0
21.5
263
1404
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
2.7
20.9
118
456
306
Kela drug reimbursment
Erythropoietin and darbepoetin
7.4
19.5
28
38
XW000, ,
SPAT
40.3
19.5
24
6
D73.5
ICD-10 Finland
Infarction of spleen
20.2
19.0
28
14
20899
ICD-8 Finland
Polycythaemia vera
+∞
18.8
18
*
B01AA03
ATC
warfarin; systemic
1.5
18.7
658
4662
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.7
18.4
389
2444
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
5.0
18.1
38
76
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.5
17.9
767
5653
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.8
17.8
312
1862
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.7
17.1
316
1913
PH_2
NOMESCO Finland
Other procedures on veins
+∞
16.7
16
*
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.9
16.0
223
1241
A05AA02
ATC
ursodeoxycholic acid; oral
3.5
15.9
55
161
K99
ICPC
Cardiovascular disease other
2.4
15.7
106
448
2387X
ICD-9 Finland
Neoplasm of uncertain behaviour of other and unspecified sites and tissues, Other lymphatic and haematopoietic tissues[STATUS LYMPHO- ET MYELOPROLIFERATIVUS NUD]
+∞
15.6
15
*
D75
ICD-10 Finland
Other diseases of blood and blood-forming organs
160.8
15.5
16
*
SPAT1088
SPAT
Blood transfusion
5.2
15.3
31
60
D69.1
ICD-10 Finland
Qualitative platelet defects
19.2
14.2
21
11
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
4.2
14.1
37
89
Z3231
NOMESCO Finland
Registered nurse
1.4
14.1
783
6015
I50.9
ICD-10 Finland
Heart failure, unspecified
1.5
13.9
502
3555
D46.2
ICD-10 Finland
Refractory anaemia with excess of blasts [RAEB]
34.2
13.5
17
5
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
13.2
391
2656
J01DB01
ATC
cefalexin; oral
1.4
13.2
2390
21912
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
1.9
12.9
168
916
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.6
12.8
348
2317
D68.8
ICD-10 Finland
Other specified coagulation defects
3.7
12.8
39
105
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
15.5
12.6
20
13
127
Kela drug reimbursment
Transplant complication
3.2
12.6
49
155
2387B
ICD-9 Finland
Neoplasm of uncertain behaviour of other and unspecified sites and tissues, Other lymphatic and haematopoietic tissues[THROMBOCYTHAEMIA IDIOPATHICA]
+∞
12.5
12
*
L57.0
ICD-10 Finland
Actinic keratosis
1.5
12.2
366
2492
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
3.1
12.1
50
164
D47.7
ICD-10 Finland
Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
21.4
12.0
17
8
C90.0
ICD-10 Finland
Multiple myeloma
3.0
11.6
49
163
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
2.6
11.6
68
270
C94.5
ICD-10 Finland
Acute myelofibrosis
+∞
11.5
11
*
UJF30
NOMESCO Finland
Ileoscopy through colon
1.6
11.5
303
2004
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
1.8
11.3
178
1029
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
2.4
11.1
76
324
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
20.1
11.1
16
8
D73.1
ICD-10 Finland
Hypersplenism
20.1
11.1
16
8
R71
ICD-10 Finland
Abnormality of red blood cells
8.1
11.1
24
30
K29
ICPC
Cardiovascular sympt/complt other
1.9
11.0
148
816
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
2.2
11.0
88
402
D47
ICD-10 Finland
Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
43.5
10.9
13
*
WZC00
NOMESCO Finland
Treatment plan or consultation
1.3
10.8
1012
8354
T14.5
ICD-10 Finland
Injury of blood vessel(s) of unspecified body region
3.9
10.6
31
81
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
2.1
10.6
105
521
A46
ICD-10 Finland
Erysipelas
1.4
10.6
449
3270
D64.9
ICD-10 Finland
Anaemia, unspecified
1.5
10.5
354
2467
2387A
ICD-9 Finland
Neoplasm of uncertain behaviour of other and unspecified sites and tissues, Other lymphatic and haematopoietic tissues[MYELOFIBROSIS]
+∞
10.4
10
*
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.4
10.4
509
3802
Z2221
NOMESCO Finland
Medical doctor
1.3
10.4
720
5687
H02AB06
ATC
prednisolone; systemic
1.3
10.4
1367
11788
V03AC03
ATC
deferasirox; oral
32.6
10.3
13
*
D46.0
ICD-10 Finland
Refractory anaemia without ring sideroblasts, so stated
18.8
10.3
15
8
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
1.8
10.2
158
910
A02BC02
ATC
pantoprazole; systemic
1.3
10.2
2024
18365
B86
ICPC
OTHER HAEMATOLOGICAL ABNORMALITY
40.2
10.0
12
*
J01MA12
ATC
levofloxacin; systemic
1.4
9.9
535
4061
C03DA01
ATC
spironolactone; oral
1.4
9.8
388
2788
B01AB04
ATC
dalteparin; parenteral
1.8
9.7
148
848
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.3
9.6
728
5816
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.6
9.6
253
1671
C07AB07
ATC
bisoprolol; oral
1.3
9.6
1526
13420
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.3
9.5
796
6450
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
30.1
9.4
12
*
L04AD01
ATC
ciclosporin; systemic
2.6
9.3
51
196
XQ848
NOMESCO Finland
Dermatological photography
2.0
9.3
92
457
M10.9
ICD-10 Finland
Gout, unspecified
1.6
9.3
223
1442
PD4AD
NOMESCO Finland
CT of lower extremity arteries
3.3
9.3
34
104
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.3
9.3
601
4690
NHQ40
NOMESCO Finland
Amputation of toe
2.6
9.2
53
209
ZY010
NOMESCO Finland
Hospital outpatient
1.9
9.2
115
620
AA1AD
NOMESCO Finland
CT of head and brain
1.3
9.2
894
7387
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
2.6
9.0
52
206
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
2.2
8.9
73
337
TPH04
NOMESCO Finland
Cathetrisation of vein
1.3
8.9
624
4923
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.5
8.9
30
87
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
8.9
1149
9829
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
1.9
8.8
113
614
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.7
8.8
383
5136
B02BX05
ATC
eltrombopag; oral
10.7
8.8
16
15
ZX120
NOMESCO Finland
Intravenous
1.5
8.8
260
1763
WW200
NOMESCO Finland
Immunization
2.2
8.7
72
335
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
2.3
8.5
60
260
129
Kela drug reimbursment
Idiopathic thrombocytopaenia or granulocytopenia
6.9
8.5
20
29
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
1.8
8.5
125
710
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.5
8.5
245
1652
D58.2
ICD-10 Finland
Other haemoglobinopathies
20.1
8.5
12
6
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.5
8.4
267
1836
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.3
8.3
552
4317
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.5
8.2
241
1630
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.4
8.0
440
3343
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.4
8.0
389
2898
R58
ICD-10 Finland
Haemorrhage, not elsewhere classified
2.5
8.0
48
194
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
1.6
8.0
187
1204
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.4
7.9
325
2352
9989/3-C42.1
ICD-O-3
Myelodysplastic syndrome, NOS, of bone marrow
7.8
7.9
17
22
ZYC01
NOMESCO Finland
Remote contact by phone
1.7
7.8
154
949
M79.6
ICD-10 Finland
Pain in limb
1.2
7.8
1194
10373
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.6
7.7
194
1270
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.3
7.7
922
7786
L17
ICPC
Foot/toe symptom/complaint
1.3
7.5
842
7047
I50.0
ICD-10 Finland
Congestive heart failure
1.5
7.5
243
1678
I67.6
ICD-10 Finland
Nonpyogenic thrombosis of intracranial venous system
7.1
7.5
17
24
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.3
7.5
555
4408
R51.80
ICD-10 Finland
Headache
1.4
7.4
369
2758
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.3
7.4
490
3829
D69.9
ICD-10 Finland
Haemorrhagic condition, unspecified
4.0
7.3
20
50
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.4
7.3
337
2485
WA010
NOMESCO Finland
Adjuvant whole body radiotherapy
+∞
7.3
7
*
L01EJ04, ,
ATC
+∞
7.3
7
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
2.3
7.2
54
241
WX892
NOMESCO Finland
Monitored bed care
1.5
7.2
212
1436
B01AB10
ATC
tinzaparin; parenteral
1.4
7.2
302
2191
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
1.8
7.2
103
581
TQW99
NOMESCO Finland
Other minor procedure on skin
1.6
7.2
153
962
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
2.7
7.1
37
139
B59
ICPC
Blood and Immunity, Other therap proced/minor surg NEC
30.1
7.1
9
*
R06.0
ICD-10 Finland
Dyspnoea
1.3
7.1
791
6612
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
7.9
7.1
15
19
S91.0
ICD-10 Finland
Open wound of ankle
2.8
7.1
34
123
I82.0
ICD-10 Finland
Budd-Chiari syndrome
13.8
6.9
11
8
N02AX02
ATC
tramadol; systemic, rectal
1.2
6.8
1204
10576
JN3AD
NOMESCO Finland
Abdominal CT examination
1.4
6.8
364
2753
I73.8
ICD-10 Finland
Other specified peripheral vascular diseases
9.3
6.8
13
14
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
6.1
6.8
17
28
L71.9
ICD-10 Finland
Rosacea, unspecified
2.0
6.8
68
342
-69
ICPC
Other reason for encounter NEC
1.8
6.7
104
601
R89.8
ICD-10 Finland
Abnormal findings in specimens from other organs, systems and tissues, other abnormal findings
22.6
6.7
9
*
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
7.8
6.6
14
18
D72.9
ICD-10 Finland
Disorder of white blood cells, unspecified
5.9
6.6
17
29
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
1.8
6.5
98
562
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.5
6.5
233
1643
B01AC04
ATC
clopidogrel; oral
1.3
6.5
498
3967
ZXE00
NOMESCO Finland
One hour or less
1.2
6.4
1004
8695
K49
ICPC
Cardiovascular, Other preventive procedure
70.0
6.4
7
*
L03AB01
ATC
interferon alfa natural; parenteral
70.0
6.4
7
*
J05AX18
ATC
letermovir; oral
70.0
6.4
7
*
NGQ20
NOMESCO Finland
Amputation of lower leg
3.3
6.4
23
70
X59
ICD-10 Finland
Exposure to unspecified factor
1.3
6.4
480
3813
J02AC03
ATC
voriconazole; systemic
6.5
6.3
15
23
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
2.9
6.3
28
97
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.5
6.3
199
1370
28999
ICD-8 Finland
Other disease of blood and blood-forming organs, Other and unspecified
+∞
6.3
6
*
175
Kela drug reimbursment
Deferasirox
+∞
6.3
6
*
DKW00
NOMESCO Finland
Cauterisation of mucosa of nose
2.6
6.2
33
126
UJF32
NOMESCO Finland
Coloscopy
1.2
6.2
737
6193
K93
ICPC
Pulmonary embolism
2.6
6.2
35
138
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
2.2
6.2
50
232
D69.5
ICD-10 Finland
Secondary thrombocytopenia
5.7
6.1
16
28
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.4
6.1
247
1781
3039, ,
Kela drug reimbursment
8.6
6.0
12
14
1517, ,
Kela drug reimbursment
8.6
6.0
12
14
M10.4
ICD-10 Finland
Other secondary gout
6.7
6.0
14
21
L04AX02
ATC
thalidomide; oral
10.0
6.0
11
11
J01FF01
ATC
clindamycin; systemic
1.2
6.0
699
5857
3AC01, ,
NOMESCO Finland
2.7
6.0
30
111
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
2503
13092
5.70
307.65
18.9
6.2
2.68
2.84
%
3.83
2444
12218
1872
7533
4.74
307.65
4.9
2.8
348.50
350.24
umol/l
0.30
1754
6534
2502
13117
5.67
307.65
19.4
6.3
8.30
9.05
%
25.97
2442
12244
2595
14632
5.71
307.65
19.1
6.2
0.22
0.19
e9/l
5.67
2414
12636
2571
14202
5.71
307.65
17.5
6.0
0.08
0.04
e9/l
82.37
2369
12071
819
502
21.80
307.65
1.4
1.5
—
—
—
0
0
2569
14161
5.72
307.65
17.6
6.0
0.64
0.60
e9/l
2.19
2367
12036
1008
500
29.37
307.65
1.3
1.2
24.14
40.71
u/l
1.36
836
435
2472
13067
5.37
307.65
18.2
6.2
61.43
57.90
%
39.66
2422
12430
1275
2899
6.77
307.65
3.9
2.6
78.85
68.64
e9/l
15.91
920
2148
2577
14440
5.61
307.65
17.9
6.1
1.93
1.89
e9/l
0.22
2420
12575
2503
13316
5.54
307.65
18.9
6.3
24.29
26.79
%
25.63
2455
12579
2497
13087
5.64
307.65
19.4
6.3
1.08
0.66
%
97.30
2438
12199
1473
3754
6.56
307.65
4.1
2.5
1.89
1.80
%
2.64
1344
3326
2122
3627
16.32
307.65
11.1
3.9
284.95
244.99
u/l
15.02
2072
3421
1078
262
62.49
307.65
1.1
1.1
—
—
—
0
0
1255
4551
3.95
289.58
3.0
2.7
22.26
21.97
%
0.28
1200
4216
1297
4913
3.82
278.71
2.9
2.6
2.41
2.28
g/l
14.24
1235
4514
2630
15976
5.22
274.60
23.7
9.3
5.36
4.20
e9/l
25.41
2442
13796
1334
5236
3.71
270.04
3.0
2.7
13.15
12.45
umol/l
2.57
1277
4860
410
791
5.82
206.09
2.8
2.3
3.28
3.61
g/l
5.02
391
754
2343
15340
3.15
167.96
10.9
6.7
12.40
11.85
umol/l
1.02
2292
14628
294
510
6.26
164.12
10.0
3.4
1.54
1.51
%
0.05
259
455
1990
12466
2.66
145.23
4.4
3.1
142.60
139.65
ug/l
0.10
1872
11507
494
1543
3.62
131.88
1.9
1.8
1.09
1.54
g/l
23.07
428
1330
1399
8039
2.35
113.84
2.8
2.4
4.79
2.87
mg/l
27.12
1215
6892
197
333
6.25
112.23
10.3
3.4
67.41
57.15
%
8.39
162
286
314
796
4.28
112.03
2.5
2.1
93.58
90.89
%
1.28
280
777
1866
12191
2.33
111.12
26.0
12.1
0.06
0.00
e9/l
4.53
1625
9910
286
791
3.88
90.05
1.8
1.5
—
—
—
0
0
60
21
29.11
89.79
1.1
1.0
—
—
—
0
0
2112
15236
2.21
89.31
9.0
7.5
1.21
1.21
mmol/l
0.06
1836
13100
2676
21508
2.77
86.06
17.7
8.5
84.70
80.80
u/l
3.75
2618
20379
250
739
3.59
71.03
3.0
2.3
178.48
198.32
%
2.64
242
701
73
6
124.56
68.15
1.1
1.0
—
—
—
0
0
1366
9033
1.91
65.46
2.1
1.7
19.84
20.34
nmol/l
0.57
1219
7546
1859
13701
1.89
62.46
8.4
6.7
1.22
1.21
mmol/l
5.27
1740
12608
254
852
3.16
58.75
3.3
2.8
1.38
1.66
mg/l
7.50
245
763
1805
13435
1.82
55.97
2.7
2.2
91.77
94.98
pmol/l
2.30
1143
7014
554
2807
2.19
54.60
2.9
2.7
66.82
66.24
g/l
0.93
508
2565
1790
13449
1.78
52.13
6.5
5.1
35.68
35.14
g/l
3.76
1703
12584
183
554
3.45
49.88
7.4
5.0
1072.40
619.49
iu/ml
0.36
20
78
600
3285
2.02
47.56
4.9
2.6
7.20
8.69
umol/l
1.42
546
2912
1100
7340
1.77
46.90
5.8
4.2
82.96
87.33
%
6.58
1053
7181
773
4670
1.87
45.53
2.8
2.0
31.75
29.76
s
12.07
734
4542
704
4143
1.90
44.90
5.1
5.8
1.06
1.04
mmol/l
1.74
664
3836
79
138
5.85
43.34
8.1
3.0
1.23
1.14
%
0.18
79
138
282
1172
2.55
43.33
3.3
3.6
37.24
67.97
mg/l
1.46
255
1000
282
1173
2.54
43.25
3.3
3.6
49.20
103.29
mg/l
0.59
254
1000
428
2142
2.16
42.79
2.9
3.0
10.52
10.67
g/l
0.23
398
1969
2109
17118
1.72
41.89
6.3
5.2
6.60
6.80
mmol/l
5.28
2049
16340
934
6107
1.76
41.70
2.1
1.7
1.15
1.40
mg/l
1.97
741
4798
2406
20335
1.81
40.76
5.7
4.6
11.97
13.43
mm/h
4.49
2282
18934
354
1691
2.23
39.61
2.0
1.9
1.50
1.42
g/l
0.22
329
1544
142
439
3.34
37.39
3.3
2.5
389.30
1970.91
u/ml
—
10
34
802
5158
1.75
37.22
3.8
3.2
0.82
0.82
mmol/l
0.35
766
4848
80
166
4.92
36.33
1.6
1.5
—
—
—
0
0
80
166
4.92
36.33
1.6
1.5
—
—
—
0
0
299
1387
2.28
35.78
2.8
2.4
3.52
3.72
g/l
1.11
272
1265
299
1388
2.28
35.71
2.8
2.4
4.19
4.20
g/l
0.09
273
1267
299
1388
2.28
35.71
2.8
2.4
6.82
7.44
g/l
9.49
273
1265
243
1047
2.43
34.39
3.3
3.4
5.26
4.01
ratio
0.17
152
615
282
1299
2.29
34.27
2.9
2.5
2.94
2.91
g/l
0.14
255
1177
824
5513
1.67
32.34
1.9
1.8
1073.89
1165.79
nmol/l
2.23
625
4145
257
1210
2.23
29.54
3.0
2.5
1.46
1.06
g/l
0.81
221
1033
1747
14182
1.53
28.68
21.8
17.2
1.36
1.30
inr
4.47
1487
11893
252
1194
2.21
28.49
2.9
2.5
11.03
10.34
g/l
1.27
223
1062
222
1013
2.28
27.48
3.0
2.4
0.02
0.02
g/l
0.05
194
907
215
977
2.29
26.87
2.9
2.4
0.00
0.00
g/l
-0.00
184
853
203
904
2.33
26.59
3.0
2.4
0.00
0.00
g/l
-0.00
184
852
29
5
58.51
25.01
1.0
1.0
—
—
—
0
0
1275
9942
1.48
23.75
3.4
3.3
2124.04
1516.26
ng/l
2.38
1122
8654
40
72
5.62
21.32
1.3
1.2
69.04
87.00
%
2.40
24
38
761
5450
1.53
20.92
2.3
1.9
—
—
—
0
0
723
5158
1.52
20.12
1.6
1.5
2.42
2.57
g/l
0.98
468
3070
39
73
5.40
19.95
1.4
1.5
73.25
84.53
%
0.79
24
40
34
57
6.02
19.49
1.4
1.5
—
—
—
0
0
453
2919
1.65
19.48
6.0
7.2
9.98
10.55
mmol/l
0.95
429
2792
131
552
2.43
19.44
2.3
1.6
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
29
44
6.64
18.30
1.3
1.2
68.00
72.42
%
0.18
16
12
29
44
6.64
18.30
1.3
1.2
70.06
78.54
%
0.47
16
13
169
814
2.14
18.29
2.3
1.5
—
—
—
0
0
96
361
2.71
18.01
1.2
1.2
2.40
3.93
u/ml
0.73
45
125
368
2295
1.68
17.88
2.0
1.6
—
—
—
0
0
2774
25863
1.68
17.48
30.8
18.2
20.95
25.87
mg/l
15.62
2466
21742
391
2505
1.64
17.08
3.4
4.0
1.22
1.23
mmol/l
2.10
335
2174
108
447
2.47
16.69
1.2
1.2
285.09
272.21
u/ml
0.15
65
260
161
789
2.10
16.67
2.2
1.5
—
—
—
0
0
51
141
3.66
16.05
2.0
2.4
79.46
99.33
%
3.39
46
135
81
298
2.76
15.89
2.9
1.6
—
—
—
0
0
89
346
2.62
15.68
1.1
1.1
—
—
—
0
0
105
442
2.42
15.66
1.3
1.4
165.90
159.22
au/ml
0.21
29
132
54
158
3.46
15.63
3.9
2.2
207.45
223.76
e6/l
0.20
47
140
90
353
2.60
15.58
1.2
1.2
4.04
6.06
u/ml
0.50
47
154
1131
9129
1.38
15.33
4.4
3.2
32.14
37.98
u/l
1.74
1077
8588
111
491
2.31
14.83
1.4
1.3
—
—
—
0
0
159
819
1.99
14.39
3.7
3.6
2.60
1.96
index
0.17
94
421
82
320
2.60
14.37
2.9
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
197
1092
1.86
14.33
3.8
2.9
0.37
0.36
iu/ml
0.12
115
598
2609
24209
1.49
14.26
5.6
4.5
1.30
1.29
mmol/l
0.56
2465
21926
39
97
4.06
14.25
1.2
1.4
—
—
—
0
0
67
238
2.86
14.06
2.6
2.4
20.76
39.63
iu/ml
—
10
35
41
111
3.73
13.34
3.8
1.7
—
—
—
0
0
40
109
3.70
12.91
3.8
1.7
—
—
—
0
0
40
109
3.70
12.91
3.8
1.7
—
—
—
0
0
82
338
2.46
12.86
1.1
1.1
109.30
114.87
%
0.90
77
307
391
2673
1.53
12.78
2.1
2.3
412.60
379.11
nmol/l
2.11
363
2452
2306
21054
1.37
12.74
43.5
22.3
15.61
13.76
%
180.64
2293
20748
48
149
3.26
12.72
3.4
1.6
—
—
—
0
0
48
149
3.26
12.72
3.4
1.6
—
—
—
0
0
48
149
3.26
12.72
3.4
1.6
—
—
—
0
0
48
149
3.26
12.72
3.4
1.6
—
—
—
0
0
228
1383
1.70
12.21
2.1
1.9
1.54
2.35
ug/l
0.72
200
1214
23
23
10.07
11.97
1.4
1.6
—
—
—
0
0
26
55
4.76
11.65
1.5
1.3
—
—
—
0
0
552
4116
1.41
11.49
2.0
1.8
—
—
—
0
0
423
3006
1.47
11.40
2.1
2.2
0.20
0.20
g/l
0.09
391
2793
1520
13196
1.30
11.30
5.3
2.8
—
—
estimate
—
0
0
70
287
2.47
11.15
1.3
1.2
—
—
—
0
0
145
791
1.87
11.13
1.5
1.6
0.22
0.24
g/l
1.07
135
757
148
816
1.85
10.99
1.4
1.6
1.12
1.19
g/l
2.32
139
780
114
576
2.02
10.96
1.4
1.4
—
—
—
0
0
193
1154
1.72
10.90
2.3
2.1
340.88
669.44
ug/l
1.04
185
1096
1890
16956
1.29
10.59
4.1
3.4
58.67
53.29
u/l
1.69
1802
15730
307
2073
1.53
10.57
4.1
3.7
5.17
5.16
kpa
0.06
282
1981
46
156
2.98
10.57
4.0
2.1
1433.58
553.24
e6/l
0.51
36
127
1162
9805
1.30
10.48
3.8
3.5
51.99
77.72
e6/l
0.72
903
7567
46
157
2.96
10.45
1.7
2.7
34.35
40.84
%
1.13
20
90
69
290
2.41
10.44
1.2
1.2
50.40
58.51
u/l
0.93
64
258
126
671
1.91
10.43
1.5
1.4
—
—
—
0
0
306
2078
1.52
10.26
1.8
1.7
—
—
—
0
0
130
704
1.88
10.23
1.2
1.3
—
—
—
0
0
41
133
3.11
10.17
1.5
2.6
1493.76
1160.93
u/ml
0.28
41
133
1126
9490
1.29
10.16
2.2
2.2
134.45
217.45
u/l
5.29
1057
8952
884
7214
1.32
10.15
5.3
2.4
—
—
—
0
0
1683
14937
1.28
9.98
4.3
4.2
0.01
0.11
estimate
0.53
452
3040
1674
14851
1.28
9.95
4.3
4.2
5.41
3.79
estimate
0.16
476
3264
1654
14660
1.27
9.87
4.3
4.2
0.00
0.00
estimate
0.50
460
3167
63
261
2.44
9.86
2.9
1.5
—
—
—
0
0
63
261
2.44
9.86
2.9
1.5
—
—
—
0
0
63
261
2.44
9.86
2.9
1.5
—
—
—
0
0
1274
10952
1.28
9.70
4.5
4.1
105.82
110.35
e6/l
0.08
933
7859
1014
8480
1.29
9.58
3.7
3.4
0.43
0.48
e6/l
0.24
766
6315
263
1757
1.54
9.51
3.8
3.6
2.07
2.00
mmol/l
0.09
186
1299
48
178
2.72
9.41
1.8
2.0
—
—
—
0
0
19
37
5.16
9.35
1.1
1.5
10.00
5.88
nmol/l
0.69
14
32
39
130
3.03
9.27
1.1
1.2
1.11
1.06
ratio
1.38
32
105
183
1129
1.66
9.23
2.0
1.9
—
—
—
0
0
837
6855
1.30
9.20
3.0
2.8
4.46
5.43
e6/l
2.25
774
6267
195
1226
1.63
9.13
2.7
2.0
—
—
—
0
0
923
7667
1.29
9.09
4.0
3.7
0.01
0.14
estimate
0.69
417
2467
129
728
1.81
8.94
1.9
2.0
15.74
12.31
mg/l
1.12
114
670
2641
25018
1.37
8.83
30.9
18.0
75.85
76.36
ml/min/173m2
0.65
2510
23391
503
3852
1.36
8.75
2.1
1.9
—
—
—
0
0
1214
10470
1.26
8.71
3.3
3.6
2.34
2.36
mmol/l
3.21
1101
9457
243
1628
1.53
8.68
2.8
3.4
4.35
4.42
pmol/l
0.62
203
1433
107
579
1.88
8.50
1.5
1.4
—
—
—
0
0
29
85
3.43
8.49
1.0
1.2
—
—
—
0
0
2799
26810
1.45
8.48
33.1
22.0
139.43
139.65
mmol/l
4.27
2762
26295
328
2349
1.44
8.42
3.1
2.8
57.35
62.73
ml/min/173m2
2.37
198
1029
2801
26849
1.44
8.29
35.0
22.2
4.02
3.99
mmol/l
7.21
2760
26288
289
2029
1.47
8.23
7.9
7.8
24.67
24.97
mmol/l
0.58
289
2021
64
291
2.22
8.17
2.8
2.9
—
—
—
0
0
91
476
1.94
8.02
1.5
1.4
—
—
—
0
0
1311
11486
1.24
7.98
4.6
4.2
46.12
102.51
ng/l
0.85
1041
8688
84
433
1.97
7.74
6.8
6.6
11.90
12.42
mg/l
0.45
78
405
1076
9254
1.25
7.64
3.0
2.7
53.61
69.76
u/l
1.19
994
8558
2196
20421
1.26
7.54
4.8
4.5
15.15
14.95
pmol/l
3.25
2026
18547
1452
12915
1.23
7.53
2.8
2.5
78.37
78.98
nmol/l
0.35
1304
11485
2557
24243
1.31
7.42
6.2
5.6
2.07
1.98
mu/l
2.99
2419
22191
2648
25247
1.33
7.25
6.5
5.3
1.32
1.46
mmol/l
57.98
2521
23141
410
3128
1.36
7.24
3.9
3.7
—
—
—
0
0
32
111
2.90
7.16
42.8
28.3
121.84
114.33
ug/l
0.33
32
91
77
397
1.96
7.12
1.4
1.5
—
—
—
0
0
54
245
2.23
6.98
1.6
1.5
—
—
—
0
0
2662
25427
1.33
6.98
6.6
5.4
4.13
4.54
mmol/l
85.45
2547
23470
181
1201
1.54
6.80
1.7
1.9
39.58
38.87
u/l
0.17
154
1049
751
6270
1.26
6.76
3.2
3.1
2.44
2.46
mmol/l
5.43
679
5633
33
123
2.70
6.50
1.4
5.6
70.68
60.34
mg/l
0.28
28
88
9
5
18.05
6.26
1.0
1.0
—
—
—
0
0
33
127
2.62
6.13
1.1
1.1
—
—
—
0
0
963
8343
1.22
6.07
4.3
4.3
0.00
0.00
estimate
1.34
427
2894
156
1028
1.54
6.07
1.2
1.2
0.21
0.90
u/ml
—
7
75
165
1101
1.53
6.07
1.6
1.8
5.45
7.76
iu/ml
0.72
32
256
421
3311
1.31
6.02
3.4
3.5
5.72
5.83
kpa
1.45
409
3223
714
6004
1.25
5.94
4.0
4.1
579.33
537.37
ng/l
0.04
579
4952
106
640
1.68
5.91
4.6
4.9
2.68
2.77
mmol/l
0.11
74
449
121
757
1.62
5.88
1.2
1.2
1.69
3.48
u/ml
—
7
68
106
641
1.68
5.88
4.6
4.9
5.03
5.08
kpa
0.20
106
634
16
30
5.36
5.84
1.4
1.8
—
—
—
0
0
2694
25900
1.30
5.79
7.4
6.2
2.33
2.62
mmol/l
61.59
2579
23821
407
3207
1.31
5.73
3.4
3.5
1.34
1.90
mmol/l
2.00
352
2786
469
3768
1.29
5.71
8.0
7.5
11.76
12.07
kpa
0.50
455
3621
469
3768
1.29
5.71
8.0
7.5
4.98
5.11
kpa
2.21
456
3620
45
207
2.19
5.69
1.1
1.2
140.00
117.71
titre
—
5
35
167
1135
1.50
5.65
2.7
2.7
—
—
—
0
0
120
758
1.61
5.63
1.2
1.3
3.27
8.67
u/ml
1.40
12
125
94
561
1.70
5.50
1.3
1.2
106.67
422.00
titre
—
6
50
2803
27139
1.34
5.39
27.0
12.9
25.00
25.71
u/l
1.41
2757
26284
1983
18536
1.19
5.17
5.5
5.2
2523.88
1991.46
e6/l
0.09
26
286
419
3364
1.28
5.11
8.3
7.7
94.78
95.41
%
0.97
408
3245
356
2799
1.31
5.10
2.3
2.5
33.35
39.48
u/l
1.71
304
2347
126
829
1.54
5.00
1.5
1.5
0.64
8.85
iu/ml
0.53
17
155
150
1029
1.48
4.89
1.4
1.3
—
—
—
0
0
101
635
1.61
4.87
1.2
1.2
1.31
7.47
u/ml
—
8
42
2626
25275
1.25
4.83
6.1
5.6
5.98
6.03
mmol/l
1.35
2438
22972
367
2920
1.29
4.81
7.2
7.2
1.41
1.36
mmol/l
0.34
361
2871
109
701
1.58
4.79
1.7
1.5
—
—
—
0
0
1218
10971
1.18
4.76
4.3
4.2
0.01
0.28
estimate
0.77
419
2589
2587
24867
1.24
4.76
7.4
7.0
38.12
39.93
mmol/mol
24.20
2467
23045
92
569
1.64
4.75
1.3
1.2
24.00
48.52
u/ml
—
5
63
318
2488
1.31
4.72
3.3
3.8
85.13
93.61
ng/l
1.12
278
2118
30
126
2.39
4.72
1.5
5.8
—
59.54
—
0
26
456
3737
1.26
4.69
8.1
7.4
0.93
0.98
mmol/l
0.09
374
3079
155
1081
1.46
4.66
4.4
3.9
24.50
24.92
mmol/l
0.98
137
990
70
406
1.74
4.59
1.5
1.5
—
—
—
0
0
34
158
2.16
4.27
1.2
1.2
—
—
—
0
0
17
56
3.05
4.24
1.8
1.4
—
—
—
0
0
105
691
1.54
4.22
1.1
1.2
—
9.20
—
0
6
198
1474
1.37
4.14
4.5
5.0
1.85
1.57
%
1.72
190
1394
63
367
1.73
4.11
1.2
1.3
289.16
316.03
pmol/l
0.33
50
316
573
4887
1.21
4.04
3.5
3.2
1.60
2.41
e6/l
1.97
266
2439
36
176
2.06
4.00
1.5
1.5
8.29
6.38
u/l
0.15
31
145
381
3125
1.25
3.89
9.0
8.2
118.86
120.83
g/l
0.87
375
3050
120
827
1.47
3.89
1.7
1.7
—
—
—
0
0
2814
27442
1.27
3.71
41.5
24.2
81.68
80.47
umol/l
1.09
2790
27092
14
39
3.60
3.69
1.4
1.0
—
—
—
0
0
55
321
1.73
3.61
1.1
1.1
1.22
3.35
—
5
48
7
9
7.79
3.56
2.0
1.1
—
—
—
0
0
64
391
1.65
3.55
1.1
1.1
—
10.75
—
0
16
19
74
2.58
3.54
1.1
1.0
—
—
—
0
0
25
111
2.26
3.54
1.2
1.5
—
1687199.83
—
0
6
94
631
1.50
3.50
1.2
1.1
6.04
4.43
—
7
67
99
672
1.49
3.50
1.4
1.3
—
—
—
0
0
1531
14265
1.14
3.44
2.8
2.7
—
—
—
0
0
673
5904
1.18
3.43
1.4
1.3
1.86
1.36
u/ml
0.36
133
1504
564
4874
1.19
3.43
1.3
1.3
30.12
35.66
iu/ml
0.51
166
1499
61
372
1.65
3.42
1.3
1.3
0.21
0.24
nmol/l
0.24
42
300
102
1458
0.69
3.41
1.7
1.8
3.27
3.46
mmol/l
1.01
67
1047
13
37
3.52
3.40
1.5
1.0
—
—
—
0
0
1223
11238
1.15
3.34
2.0
1.9
1.40
1.34
mmol/l
1.61
1054
9316
8
14
5.73
3.34
3.3
4.6
—
—
—
0
0
336
2771
1.24
3.29
2.9
2.9
4.41
4.48
kpa
0.23
327
2691
40
219
1.84
3.27
1.1
1.1
—
—
—
0
0
38
205
1.86
3.25
1.3
1.5
—
—
—
0
0
9
19
4.75
3.23
1.0
1.4
—
—
—
0
0
62
386
1.62
3.23
2.5
1.3
—
—
—
0
0
75
491
1.54
3.17
1.2
1.5
32.04
31.84
g/l
0.05
67
446
608
5325
1.18
3.15
3.4
3.1
0.92
1.18
e6/l
0.97
305
2879
855
7695
1.15
3.10
3.3
3.2
0.00
0.03
1.46
19
228
61
383
1.60
3.09
2.6
1.3
—
—
—
0
0
34
181
1.89
3.05
1.3
1.5
—
—
—
0
0
78
521
1.51
3.02
1.7
2.0
4.93
4.78
mmol/24h
0.16
72
444
118
855
1.40
2.99
1.8
1.8
—
—
—
0
0
155
2021
0.75
2.95
2.0
2.1
3.73
3.47
ratio
1.63
118
1620
60
381
1.59
2.92
1.3
1.4
114075.73
90993.81
e6/l
0.15
37
210
27
136
1.99
2.85
1.7
1.6
43.01
39.83
g/l
2.72
27
136
56
354
1.59
2.79
1.3
1.3
272.66
276.31
mosm/kgh2o
0.56
44
264
36
202
1.79
2.77
1.1
1.1
—
—
—
0
0
27
138
1.96
2.75
2.0
1.3
—
—
—
0
0
27
138
1.96
2.75
2.0
1.3
—
—
—
0
0
34
188
1.82
2.74
1.4
1.5
—
—
—
0
0
23
111
2.08
2.72
1.7
1.3
—
—
—
0
0
38
218
1.75
2.72
1.1
1.1
—
—
—
0
0
94
672
1.41
2.62
2.4
2.8
37.32
36.08
umol/l
0.12
84
598
36
207
1.75
2.57
1.1
1.1
—
—
—
0
0
36
207
1.75
2.57
1.1
1.1
—
—
—
0
0
65
434
1.51
2.57
1.2
1.4
1837.16
3743.14
e6/l
0.45
45
302
226
1840
1.25
2.53
9.4
9.9
15.67
15.88
%
0.47
221
1774
56
365
1.54
2.48
2.7
1.4
—
—
—
0
0
21
102
2.07
2.47
2.0
1.9
1335.85
21749.36
e6/l
0.55
13
55
58
382
1.53
2.46
2.6
1.3
—
—
—
0
0
23
116
1.99
2.45
2.0
2.1
492.53
821.01
e6/l
0.82
15
84
376
3231
1.19
2.45
2.4
2.3
172.22
149.75
ug/g
0.38
296
2565
311
2633
1.20
2.39
3.4
3.1
214.03
220.84
ng/l
0.11
288
2410
9
27
3.34
2.39
2.4
4.5
—
—
—
0
0
42
258
1.64
2.39
1.4
1.6
—
—
—
0
0
20
97
2.07
2.37
1.1
1.3
40.04
415.24
ug/l
0.66
13
44
30
168
1.79
2.36
1.4
1.3
1.35
1.19
nmol/l
0.39
19
120
169
1348
1.27
2.28
5.0
5.2
0.90
0.87
%
0.42
160
1271
34
201
1.70
2.24
1.8
1.3
—
—
—
0
0
40
248
1.62
2.21
1.2
1.1
—
—
—
0
0
51
336
1.53
2.19
5.0
3.8
—
—
—
0
0
56
380
1.48
2.11
1.6
1.4
—
—
—
0
0
33
198
1.67
2.08
1.2
1.1
—
—
—
0
0
54
366
1.48
2.05
2.8
1.3
—
—
—
0
0
54
368
1.48
2.00
2.8
1.3
—
—
—
0
0
37
232
1.60
1.99
1.1
1.1
—
—
—
0
0
39
248
1.58
1.98
1.0
1.1
—
—
—
0
0
202
1674
1.22
1.98
1.3
1.3
60.08
55.16
au/ml
0.12
12
114
513
4592
1.14
1.97
1.3
1.3
9.29
13.29
u/ml
0.81
178
1688
702
6414
1.12
1.94
1.7
1.8
19597563.97
26462088.88
pmol/l
0.13
546
5268
220
1843
1.21
1.94
2.5
2.5
21.88
22.32
au/ml
0.02
24
151
101
776
1.31
1.87
2.2
2.2
129.63
127.84
g/l
0.22
81
607
8
28
2.86
1.86
1.0
1.0
—
—
—
0
0
400
3539
1.15
1.83
1.4
1.4
—
—
—
0
0
178
1470
1.22
1.82
2.1
2.2
0.00
0.58
estimate
0.51
42
435
72
528
1.37
1.82
1.5
1.3
12.84
9.93
u/l
1.27
62
423
2821
27772
1.17
1.81
54.3
27.5
399.31
245.47
e9/l
307.65
2781
27174
90
684
1.33
1.81
1.4
1.6
—
—
—
0
0
32
199
1.61
1.80
1.8
1.3
—
—
—
0
0
2821
27774
1.17
1.80
54.0
27.4
94.17
91.53
fl
31.90
2799
27426
9
35
2.58
1.80
1.6
1.5
—
—
—
0
0
2821
27777
1.17
1.78
54.7
28.0
40.32
39.90
%
3.78
2799
27414
2821
27777
1.17
1.78
54.1
27.5
4.41
4.43
e12/l
0.41
2771
27075
50
345
1.46
1.78
6.3
6.2
7.66
7.58
mmol/l
0.06
42
294
11
47
2.35
1.77
1.2
1.2
—
—
—
0
0
44
296
1.49
1.77
1.5
1.7
—
1504.00
—
0
10
2821
27780
1.17
1.76
54.2
27.5
8.97
6.83
e9/l
34.88
2771
27080
26
154
1.69
1.76
2.7
3.9
—
—
—
0
0
2821
27783
1.17
1.74
54.5
27.7
131.44
133.60
g/l
8.96
2801
27449
21
117
1.80
1.74
2.1
1.8
49.73
47.35
ug/l
0.15
21
112
126
1008
1.26
1.73
1.7
1.6
0.37
0.34
mg/l
0.23
60
455
122
974
1.26
1.71
1.5
1.6
30.11
18.96
u/ml
0.40
16
188
8
31
2.58
1.66
1.6
1.5
—
—
—
0
0
195
1643
1.20
1.65
1.3
1.3
140.15
230.18
u/ml
1.65
182
1523
13
62
2.10
1.65
1.9
1.5
—
—
—
0
0
188
1579
1.20
1.65
3.5
3.6
1.02
1.02
ratio
0.25
174
1432
24
143
1.68
1.61
1.1
1.1
14.06
14.95
u/ml
—
5
57
239
2057
1.18
1.60
2.5
3.0
126.71
128.14
g/l
0.38
226
1998
230
1975
1.18
1.58
8.5
6.7
24.03
24.54
mmol/l
1.14
223
1887
7
26
2.70
1.58
2.3
2.9
0.43
0.77
u/field
—
7
26
20
114
1.76
1.56
2.2
2.9
36.90
19.43
mu/l
0.81
20
109
96
755
1.28
1.54
1.2
1.2
—
—
—
0
0
14
71
1.98
1.53
1.2
1.8
—
—
—
0
0
2025
20848
0.92
1.51
46.8
23.6
326.02
331.65
g/l
55.30
2013
20718
197
1679
1.19
1.49
4.1
3.9
45.73
47.13
%
0.34
189
1650
102
813
1.26
1.48
1.4
1.3
26.22
29.82
iu/l
0.64
90
693
13
65
2.00
1.48
1.0
1.2
—
—
—
0
0
110
885
1.25
1.48
2.1
1.3
—
—
—
0
0
96
761
1.27
1.47
1.2
1.1
—
—
—
0
0
30
195
1.54
1.45
1.7
2.1
7.78
8.15
mmol/l
0.26
30
195
191
1629
1.18
1.45
1.6
1.5
—
—
—
0
0
396
3562
1.13
1.45
5.6
5.2
31.56
33.19
%
2.46
299
2263
81
632
1.29
1.41
1.7
1.3
—
—
—
0
0
81
632
1.29
1.41
1.7
1.3
—
—
—
0
0
7
29
2.42
1.39
1.0
1.1
91.43
94.90
titre
—
7
29
81
634
1.29
1.38
1.2
1.1
15.76
5.91
eliau/ml
—
9
56
13
67
1.94
1.38
2.4
2.5
5.38
476.74
ug/l
0.57
13
67
46
631
0.72
1.37
1.2
1.2
1.43
1.54
g/l
2.45
46
631
177
1508
1.18
1.37
3.1
3.3
24.70
25.30
mmol/l
1.41
167
1455
5
17
2.94
1.36
1.4
1.0
—
—
—
0
0
41
571
0.71
1.35
1.1
1.1
0.64
0.66
ratio
0.18
11
79
15
260
0.57
1.34
1.3
1.5
—
—
—
0
0
26
167
1.56
1.34
2.1
2.4
—
—
—
0
0
26
169
1.54
1.28
1.0
1.1
—
—
—
0
0
5
18
2.78
1.28
1.2
1.0
39.94
38.10
%
—
5
18
5
18
2.78
1.28
1.2
1.0
24.02
20.97
%
—
5
18
5
18
2.78
1.28
1.2
1.0
9.04
7.74
%
—
5
18
29
195
1.49
1.24
4.2
1.7
—
—
—
0
0
28
187
1.50
1.23
1.0
1.1
37.54
41.83
mg/l
0.35
23
156
27
179
1.51
1.23
2.0
1.7
697.10
334.81
mu/l
0.52
21
137
42
305
1.38
1.21
4.5
3.6
14.24
11.61
index
1.21
33
167
18
109
1.66
1.18
2.1
2.6
0.62
0.61
mmol/l
0.16
18
109
12
64
1.88
1.18
1.0
1.2
—
—
—
0
0
112
934
1.21
1.14
1.4
1.4
279.44
273.84
ug/g
0.11
70
559
52
397
1.32
1.11
1.1
1.1
13.10
21.63
au/ml
—
7
78
85
693
1.23
1.08
1.6
2.2
60.77
60.81
%
0.01
85
688
24
161
1.49
1.06
1.0
1.1
1.84
10.07
iu/ml
—
5
46
11
60
1.84
1.02
2.1
1.1
—
—
—
0
0
138
1186
1.17
1.02
2.2
3.2
397.43
4253.82
u/ml
0.96
117
1024
27
380
0.71
1.00
1.3
1.6
1026.29
963.97
mu/l
0.08
18
305
7
37
1.89
0.94
2.1
2.5
12.40
17.77
umol/l
—
7
37
76
625
1.22
0.93
1.2
1.4
32.19
37.23
e6/l
0.09
53
457
245
2209
1.12
0.93
1.5
1.5
—
—
—
0
0
295
2688
1.11
0.92
1.6
1.8
1.52
1.53
%
0.20
252
2302
18
118
1.53
0.90
1.1
1.9
2.73
5.88
ug/l
—
10
89
6
29
2.07
0.89
1.7
1.2
—
—
—
0
0
14
218
0.64
0.88
1.4
1.6
64.29
60.23
ug/l
—
7
175
19
127
1.50
0.88
1.9
1.9
77.09
97.78
umol/l
0.30
11
73
6
30
2.00
0.87
4.7
5.5
51.17
55.12
ug/min
—
6
25
612
6478
0.93
0.86
4.4
4.5
1.02
1.25
kg/l
0.50
428
4378
76
631
1.21
0.86
1.3
1.4
924.47
1337.25
e6/l
0.20
58
489
13
204
0.64
0.85
1.5
1.5
—
—
—
0
0
24
171
1.41
0.83
1.3
1.8
—
—
—
0
0
298
2739
1.10
0.80
2.3
2.4
5.25
7.20
ug/l
2.00
235
2409
10
58
1.73
0.79
1.1
1.1
—
—
—
0
0
17
114
1.49
0.79
1.2
1.3
111.61
168.65
mmol/24h
3.19
17
114
13
82
1.59
0.78
1.5
1.2
23.60
16.75
%
—
5
12
77
650
1.19
0.76
6.6
7.0
105.10
105.10
mmol/l
0.00
68
580
12
185
0.65
0.75
1.0
1.5
112.17
84.97
umol/l
0.57
12
185
95
818
1.17
0.75
1.3
1.4
—
—
—
0
0
275
2535
1.09
0.72
2.6
2.6
0.41
0.46
e6/l
0.22
263
2431
7
40
1.75
0.71
1.4
1.2
—
—
—
0
0
7
40
1.75
0.71
1.0
1.2
—
—
—
0
0
19
134
1.42
0.71
1.2
1.2
0.47
0.52
ratio
—
6
80
23
169
1.36
0.69
1.6
1.2
—
—
—
0
0
27
204
1.33
0.68
1.4
1.2
—
—
—
0
0
22
161
1.37
0.68
1.2
1.1
—
—
—
0
0
13
192
0.68
0.68
1.3
1.6
—
—
—
0
0
7
43
1.63
0.66
1.4
1.2
—
—
—
0
0
178
1614
1.11
0.66
1.2
1.2
103.72
134.50
u/ml
0.62
56
586
5
28
1.79
0.66
1.0
1.0
—
—
—
0
0
25
188
1.33
0.66
1.4
1.3
9.63
9.76
mmol/l
0.05
25
179
11
167
0.66
0.66
1.5
1.7
—
—
—
0
0
23
171
1.35
0.65
1.6
1.2
—
—
—
0
0
90
786
1.15
0.62
3.8
3.4
0.78
0.81
nmol/l
0.25
70
643
50
416
1.21
0.61
1.2
1.1
—
—
—
0
0
32
253
1.27
0.61
1.2
1.5
20.87
28.79
%
0.68
15
152
8
51
1.57
0.60
1.0
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
20
148
1.35
0.59
1.3
1.1
—
—
—
0
0
37
299
1.24
0.59
1.2
1.1
2.82
2.07
eliau/ml
0.36
12
111
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
26
201
1.30
0.59
1.6
1.8
120.44
119.80
ng/l
0.01
26
201
63
538
1.17
0.58
1.2
1.3
149.17
222.83
miu/ml
0.82
23
216
6
36
1.67
0.56
1.0
1.2
2.65
1.86
umol/24h
—
6
36
13
90
1.45
0.55
1.1
1.2
6.80
11.99
pmol/l
—
5
35
15
205
0.73
0.54
1.4
1.5
1.00
0.96
ratio
—
6
125
15
205
0.73
0.54
1.4
1.5
0.79
1.19
ratio
—
7
125
15
205
0.73
0.54
1.4
1.5
1.58
1.22
ratio
—
6
125
543
5669
0.95
0.52
3.1
3.4
0.76
0.79
ug/l
0.20
371
3882
41
341
1.21
0.52
1.3
1.5
71.34
60.80
%
0.89
20
206
331
3504
0.94
0.51
8.1
7.5
—
—
—
0
0
9
136
0.66
0.51
1.0
1.5
56.32
54.07
ug/l
—
9
136
24
188
1.28
0.51
2.0
1.8
6.08
10.40
umol/l
0.63
17
125
29
233
1.25
0.51
4.9
5.3
53.59
36.42
u/ml
0.26
11
68
7
108
0.65
0.48
1.6
1.3
—
—
—
0
0
121
1099
1.11
0.48
1.3
1.3
—
—
—
0
0
20
155
1.29
0.46
7.0
6.8
6.59
136.86
ug/l
0.61
12
97
28
227
1.24
0.46
2.3
2.2
678.65
628.48
ml
0.31
17
147
33
396
0.83
0.45
1.3
1.6
—
—
—
0
0
96
865
1.11
0.45
6.3
3.9
3.96
3.89
mmol/l
0.81
96
857
25
201
1.25
0.45
1.8
1.3
0.46
1.79
u/ml
1.03
16
116
13
95
1.37
0.43
3.8
2.5
11.94
10.09
kpa
1.04
13
95
13
95
1.37
0.43
3.8
2.5
4.95
4.83
kpa
0.19
13
95
18
139
1.30
0.43
1.2
1.7
—
—
—
0
0
11
78
1.41
0.43
1.0
1.3
3.13
4.08
umol/l
—
6
65
8
57
1.40
0.42
6.0
8.7
8.56
5.44
kpa
—
8
57
5
33
1.52
0.41
1.2
2.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
11
79
1.39
0.40
1.3
1.1
—
—
—
0
0
355
3390
1.05
0.40
2.9
4.2
10.07
21.64
ug/l
0.89
268
2786
8
60
1.33
0.40
1.1
1.1
—
—
—
0
0
746
7678
0.96
0.40
4.1
4.8
22.30
21.92
%
0.28
373
3950
0
18
0.00
0.40
0.0
1.6
—
22.61
—
0
8
5
35
1.43
0.39
1.4
1.0
—
—
—
0
0
20
160
1.25
0.38
1.5
1.2
—
—
—
0
0
11
80
1.38
0.38
1.3
1.1
—
—
—
0
0
15
116
1.29
0.37
1.0
1.1
1530.67
1615.41
miu/ml
0.10
15
116
11
81
1.36
0.36
1.4
1.1
—
—
—
0
0
6
43
1.40
0.35
1.0
1.0
31.78
41.55
iu/ml
—
6
43
10
73
1.37
0.34
1.0
1.4
10.79
9.12
ug/l
—
10
73
11
82
1.34
0.34
1.1
1.1
—
—
—
0
0
38
435
0.87
0.33
1.2
1.1
74.00
94.24
iu/ml
—
6
87
33
287
1.15
0.30
1.1
1.0
1.75
0.95
u/ml
0.25
19
141
66
724
0.91
0.30
1.3
2.0
2.87
12.20
iu/l
0.59
23
282
12
94
1.28
0.28
1.2
2.4
39.97
102.00
ug/l
0.33
12
84
33
289
1.14
0.28
1.3
1.5
—
—
—
0
0
65
709
0.92
0.27
1.6
1.4
—
—
—
0
0
35
395
0.88
0.26
3.0
5.2
333.23
347.33
umol/l
0.24
26
347
11
86
1.28
0.26
1.8
1.6
79.73
481.87
nmol/24h
0.65
11
86
13
105
1.24
0.24
1.3
1.4
2.88
3.13
mmol/l
0.19
13
95
11
87
1.27
0.24
1.1
1.1
—
—
—
0
0
11
87
1.27
0.24
1.4
1.1
—
—
—
0
0
18
152
1.19
0.23
2.0
2.1
19.40
175.89
ug/min
—
5
35
42
380
1.11
0.23
1.1
1.1
0.55
1.29
u/ml
1.15
24
207
77
719
1.07
0.22
2.0
1.9
42.49
42.81
nmol/l
0.05
72
688
20
172
1.16
0.22
1.6
1.4
—
—
—
0
0
5
41
1.22
0.22
1.0
1.8
59.39
42.39
pmol/l
—
5
34
0
12
0.00
0.21
0.0
1.2
—
7.76
—
0
12
0
12
0.00
0.21
0.0
1.3
—
2.83
—
0
12
971
9577
1.02
0.20
5.2
5.8
2.39
3.49
ug/l
1.53
862
8597
17
146
1.17
0.19
1.6
1.5
145.23
160.70
pmol/l
0.13
17
146
119
1248
0.95
0.19
1.1
1.1
—
—
—
0
0
73
777
0.94
0.19
1.6
1.6
12524.66
15123.53
e6/l
0.32
53
526
5
67
0.75
0.17
1.0
1.4
1.25
1.17
mmol/l
—
5
67
15
129
1.16
0.17
1.1
1.1
—
—
—
0
0
17
148
1.15
0.17
1.1
1.1
0.90
1.20
u/l
—
7
74
8
72
1.11
0.16
1.3
1.1
—
—
—
0
0
8
73
1.10
0.15
1.1
1.2
—
—
—
0
0
15
130
1.15
0.15
1.1
1.1
—
—
—
0
0
29
264
1.10
0.15
1.3
1.3
—
—
—
0
0
347
3396
1.02
0.15
1.5
1.4
—
—
—
0
0
42
390
1.08
0.15
2.0
2.3
12.08
22.39
mg/l
2.73
12
138
65
614
1.06
0.15
4.4
3.7
29.70
26.99
mg/l
0.24
41
431
17
150
1.13
0.14
1.3
1.3
11.89
22.94
umol/l
4.60
17
136
210
2158
0.97
0.14
3.0
2.3
12.53
13.06
nmol/l
0.42
185
1926
55
582
0.94
0.13
1.3
1.7
0.78
0.83
nmol/l
0.25
48
483
1028
10376
0.99
0.13
3.3
3.5
7.07
7.24
mmol/l
0.60
857
8664
44
414
1.06
0.12
1.6
2.0
15413.76
3015.21
u/l
—
8
168
20
220
0.91
0.12
1.1
1.0
0.04
0.26
u/ml
—
8
76
5
48
1.04
0.09
1.2
1.1
91.22
41.94
u/ml
—
5
48
77
745
1.03
0.08
1.2
1.2
—
—
—
0
0
30
318
0.94
0.08
1.1
1.1
0.96
3.54
u/ml
3.12
19
155
24
224
1.07
0.08
1.9
2.9
22.29
31.47
mg/l
0.65
14
168
142
1389
1.02
0.08
1.8
1.8
—
—
—
0
0
155
1518
1.02
0.08
1.8
1.9
—
—
—
0
0
11
123
0.89
0.08
2.8
1.3
22.18
29.00
umol/l
1.20
11
114
10
89
1.12
0.06
1.2
1.1
—
—
—
0
0
8
95
0.84
0.06
1.1
1.2
18.38
10.03
mm/h
—
8
95
9
104
0.86
0.06
1.0
1.0
—
—
—
0
0
68
696
0.98
0.04
2.6
2.2
155.96
101.38
ug/min
0.33
38
418
73
714
1.02
0.04
2.3
3.4
57.77
716.01
u/ml
1.14
62
657
25
239
1.05
0.04
1.1
1.1
2.98
3.27
u/ml
0.06
12
103
27
259
1.04
0.04
1.9
2.0
2.42
1.59
u/field
0.42
19
136
58
568
1.02
0.03
1.4
1.5
—
—
—
0
0
74
752
0.98
0.03
2.0
1.9
—
—
—
0
0
32
311
1.03
0.02
1.1
1.1
0.14
1.19
u/ml
1.85
14
127
14
147
0.95
0.01
1.1
1.1
—
—
—
0
0
61
618
0.99
0.01
2.0
1.8
—
—
—
0
0
25
243
1.03
0.01
1.2
1.3
32.82
29.37
u/l
0.19
19
197
20
206
0.97
0.00
1.4
1.4
1.21
1.08
promille
0.13
12
163
23
236
0.97
0.00
1.1
1.2
103.09
104.19
pmol/l
0.04
23
236
15
155
0.97
0.00
2.0
1.2
218.00
136.77
nmol/l
1.92
15
155
26
259
1.00
0.00
1.1
1.0
1.17
2.09
u/ml
0.64
14
123
28
276
1.01
0.00
1.3
1.3
551895.86
70428.07
e6/l
0.86
21
183
1029
10295
1.00
0.00
4.0
4.2
12.97
8.97
mg/mmol
1.27
630
6400
26
263
0.99
0.00
1.7
1.5
0.22
0.29
nmol/l
0.69
17
199
14
137
1.02
0.00
1.3
1.4
—
—
—
0
0
9
98
0.92
-0.00
1.2
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.8
—
1.27
—
0
8
0
5
0.00
-0.00
0.0
1.0
—
1745.20
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
306.00
—
0
5
0
6
0.00
-0.00
0.0
1.2
—
1.63
—
0
6
0
6
0.00
-0.00
0.0
2.0
—
1.50
—
0
6
8
84
0.95
-0.00
1.8
1.3
94.88
107.50
%
—
8
74
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
7.2
—
67.00
—
0
6
9
96
0.94
-0.00
1.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: MYELOPROF_NONCML – Myeloproliferative diseases (CML excluded)
GWS hits: 24
This endpoint is excluded (different definition than used in FinnGen).